We are live on
!
Find out more
WCBA
Weaver C. Barksdale & Associates Portfolio holdings
AUM
$105M
1-Year Est. Return
13.81%
This Fund
S&P 500
This Quarter
Est. Return
+4.18%
1 Year Est. Return
+13.81%
3 Year Est. Return
+40.08%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$128M
AUM Growth
+$4.06M
(+3.3%)
Cap. Flow
-$394K
Cap. Flow
% of AUM
-0.31%
Top 10 Holdings %
Top 10 Hldgs %
22.1%
Holding
568
New
19
Increased
146
Reduced
195
Closed
18
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Realty Income
O
|
+$843K |
| 2 |
Amgen
AMGN
|
+$823K |
| 3 |
GameStop
GME
|
+$707K |
| 4 |
Leggett & Platt
LEG
|
+$333K |
| 5 |
Synchrony
SYF
|
+$179K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PNY
PIEDMONT NATURAL GAS CO INC(NC
PNY
|
+$1.11M |
| 2 |
Teva Pharmaceuticals
TEVA
|
+$712K |
| 3 |
KLA
KLAC
|
+$633K |
| 4 |
Walmart Inc
WMT
|
+$586K |
| 5 |
HCR
Hi-Crush Inc. Common Stock
HCR
|
+$170K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.26% |
| 2 | Consumer Discretionary | 18.62% |
| 3 | Industrials | 15.61% |
| 4 | Healthcare | 8.55% |
| 5 | Consumer Staples | 7.74% |
Similar funds
EW
AFG
ANBOT
P
SPW
SHF
NS
ACA
Weaver C. Barksdale & Associates's Q4 2015 Portfolio in Review
As of Q4 2015, Weaver C. Barksdale & Associates held 568 positions worth $128M, up 3.3% from $124M the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Weaver C. Barksdale & Associates's Q4 2015 filing shows 19 new, 146 increased, 195 reduced and 18 closed positions. Its largest new stake was Realty Income: 17,635 shares worth $882K. The largest sale was PIEDMONT NATURAL GAS CO INC(NC, an estimated $1.11M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 27% a quarter earlier, followed by Consumer Discretionary and Industrials.
- Weaver C. Barksdale & Associates's largest Q4 2015 buy was Realty Income: 17,635 shares worth $882K.
- Weaver C. Barksdale & Associates added most to Leggett & Platt in Q4 2015, an estimated $333K increase.
- Weaver C. Barksdale & Associates's biggest Q4 2015 reduction was PIEDMONT NATURAL GAS CO INC(NC, cutting an estimated $1.11M.
- Weaver C. Barksdale & Associates fully exited Teva Pharmaceuticals in Q4 2015, selling an estimated $712K.
- Weaver C. Barksdale & Associates's ten largest holdings make up 22% of its $128M portfolio in Q4 2015.
- Weaver C. Barksdale & Associates opened 19 new positions and closed 18 in Q4 2015.
- Weaver C. Barksdale & Associates's portfolio value rose 3.3% quarter-over-quarter to $128M.
Based on Weaver C. Barksdale & Associates's 13F filing for Q4 2015, filed 25 Jan 2016.